GlassScriptPhysician profile
Arun K Softa
NPI 1902954738
$5,338.72
in general payments reported to CMS, 2019-2025
39 companies · $1,144 in 2025
The $1,144 reported for 2025 was more than what 87% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,324 · 2020: $324 · 2021: $263 · 2022: $570 · 2023: $738 · 2024: $977 · 2025: $1,144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,859.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,859.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,301.25 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $748.44 | 2019-2025 | Jardiance |
| Lilly USA, LLC | $394.80 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $364.68 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Horizon Therapeutics Plc | $264.35 | 2020-2022 | |
| Amgen INC. | $214.36 | 2019-2025 | Otezla, Repatha, Evenity |
| Pfizer INC. | $212.73 | 2019-2025 | |
| Nevro Corp. | $152.54 | 2021-2023 | Senza |
| Glaxosmithkline, LLC. | $151.57 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $146.30 | 2023-2025 | |
| Biosense Webster, INC. | $143.01 | 2024-2025 | Qdot Micro, Qdot Micro Catheter |
| Amarin Pharma, INC. | $135.93 | 2019 | |
| Merck Sharp & Dohme LLC | $130.24 | 2019-2021 | |
| Phathom Pharmaceuticals, INC. | $100.09 | 2024-2025 | Voquezna |
| Abbott Laboratories | $80.57 | 2022-2025 | Freestyle Libre 3 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arun Softa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.